Cell and gene therapy consulting firm submits draft AAV purity guidance to FDA
Back in September, the FDA held a two-day adcomm on gene therapy. At the time, hopes were that talks and discussions could offer a clear …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
